grant

NSF-SNSF: Programmable and dynamically-responsive bacterial therapeutics for cancer immunotherapy

Organization University of WashingtonLocation SEATTLE, United StatesPosted 1 Mar 2025Deadline 29 Feb 2028
NSFUS FederalResearch GrantScience FoundationWA
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Living cells can act as programmable and dynamically-responsive therapeutics to treat cancer. Although engineered human T cells have been effective for cancer therapy, they are almost prohibitively expensive. In contrast, bacterial cells can be manufactured at low cost and therefore hold promise as broadly applicable therapeutics. To enable…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
NSF-SNSF: Programmable and dynamically-responsive bacterial therapeutics for cancer immunotherapy — University of Washin | Dev Procure